Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00948285 · ClinicalTrials.gov registry record · NA
Importance of Magnetic Resonance Imaging (MRI) in Treating Breast Cancer
A NA study, sponsored by Texas Tech University Health Sciences Center.
- Terminated
- Registry status
- NA
- Development phase
- 194
- Enrollment target
NCT00948285 is a NA study that was terminated before completion, run by Texas Tech University Health Sciences Center. The registered enrollment target is 194 participants.
The verdict
NCT00948285, a NA study, was terminated before completion, sponsored by Texas Tech University Health Sciences Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 194 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if the use of magnetic resonance imaging (MRI) for breast cancer translates into better surgical outcomes. MRIs may help ensure that as little healthy tissue is removed as is possible and may help prevent the need for additional surgical procedures.
Interventions
- PROCEDURE MRI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 194 participants |
| Start Date | 2009-07 |
| Est. Completion | 2018-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00948285
The ClinicalTrials.gov registry entry for NCT00948285 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 194 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Texas Tech University Health Sciences Center, which has 76 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MRI is the first listed.
NCT00948285 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00948285 about?
NCT00948285 is a clinical study titled "Importance of Magnetic Resonance Imaging (MRI) in Treating Breast Cancer". The purpose of this study is to determine if the use of magnetic resonance imaging (MRI) for breast cancer translates into better surgical outcomes. MRIs may help ensure that as little healthy tissue is removed as is possible and may help prevent the need for additional surgical procedures.
What is the current status of trial NCT00948285?
This trial is currently terminated. It is a NA study. The enrollment target is 194 participants. The study started on 2009-07. Estimated completion is 2018-12.
What interventions are being tested in trial NCT00948285?
The interventions under investigation include: MRI (PROCEDURE).
Who is sponsoring clinical trial NCT00948285?
This trial is sponsored by Texas Tech University Health Sciences Center, which has 76 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.